XML 37 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Goodwill and Intangible Assets, Net | 12 Months Ended
--- | ---
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets, Net | Goodwill and Intangible Assets, Net Goodwill Changes in the carrying amount of goodwill were as follows:
(In millions) | U.S. Pharmaceutical |  | Prescription Technology Solutions |  | Medical-Surgical Solutions |  | International |  | Corporate |  | Total
Balance, March 31, 2023 | $ | 4,050 |  |  | $ | 2,005 |  |  | $ | 2,453 |  |  | $ | 1,439 |  |  | $ | — |  |  | $ | 9,947 |
Goodwill acquired | 80 |  |  | 19 |  |  | 83 |  |  | 13 |  |  | — |  |  | 195 |
Foreign currency translation adjustments, net | — |  |  | — |  |  | — |  |  | (3) |  |  | — |  |  | (3) |
Other adjustments | (7) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (7) |
Balance, March 31, 2024 | 4,123 |  |  | 2,024 |  |  | 2,536 |  |  | 1,449 |  |  | — |  |  | 10,132 |
Goodwill acquired | 1 |  |  | 11 |  |  | — |  |  | 4 |  |  | — |  |  | 16 |
Disposals (1) | — |  |  | — |  |  | — |  |  | (46) |  |  | — |  |  | (46) |
Foreign currency translation adjustments, net | — |  |  | — |  |  | — |  |  | (80) |  |  | — |  |  | (80) |
Other adjustments | 8 |  |  | (8) |  |  | (29) |  |  | — |  |  | 29 |  |  | — |
Balance, March 31, 2025 | $ | 4,132 |  |  | $ | 2,027 |  |  | $ | 2,507 |  |  | $ | 1,327 |  |  | $ | 29 |  |  | $ | 10,022 |
(1)Goodwill related to the Canadian retail disposal group discussed in Financial Note 2, “Business Acquisitions and Divestitures,” Goodwill Impairment Charges The Company evaluates goodwill for impairment on an annual basis in the first fiscal quarter, and more frequently if indicators for potential impairment exist. Goodwill impairment testing is conducted at the reporting unit level, which is generally defined as an operating segment or one level below an operating segment (also known as a component), for which discrete financial information is available and segment management regularly reviews the operating results of that reporting unit. The fair value of the reporting units is determined using a combination of an income approach based on a DCF model and a market approach based on appropriate valuation multiples observed for the reporting unit’s guideline public companies. Fair value estimates result from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions that have been deemed reasonable by management as of the measurement date. Any material changes in key assumptions, including failure to improve operations of certain retail pharmacy stores, additional government reimbursement reductions, deterioration in the financial markets, an increase in interest rates, or an increase in the cost of equity financing by market participants within the industry, or other unanticipated events and circumstances, may affect such estimates. The discount rates are the weighted-average cost of capital measuring the reporting unit’s cost of debt and equity financing weighted by the percentage of debt and percentage of equity in a company’s target capital. The unsystematic risk premium is an input factor used in calculating the discount rate that specifically addresses uncertainty related to the reporting unit’s future cash flow projections. Fair value assessments of the reporting unit are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The annual impairment testing performed for fiscal 2025, fiscal 2024, and fiscal 2023 did not indicate any impairment of goodwill. Intangible Assets Information regarding intangible assets were as follows:
| March 31, 2025 |  | March 31, 2024
(Dollars in millions) | Weighted- Average Remaining Amortization Period (Years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount (1) |  | Accumulated Amortization (1) |  | Net Carrying Amount
Customer relationships | 10 |  | $ | 1,475 |  |  | $ | (650) |  |  | $ | 825 |  |  | $ | 1,830 |  |  | $ | (701) |  |  | $ | 1,129 |
Service agreements | 9 |  | 1,116 |  |  | (728) |  |  | 388 |  |  | 1,126 |  |  | (676) |  |  | 450
Trademarks and trade names | 13 |  | 378 |  |  | (278) |  |  | 100 |  |  | 759 |  | (395) |  |  | 364
Technology | 9 |  | 288 |  |  | (141) |  |  | 147 |  |  | 284 |  | (125) |  |  | 159
Other | 7 |  | 31 |  |  | (27) |  |  | 4 |  |  | 34 |  | (26) |  |  | 8
Total |  |  | $ | 3,288 |  |  | $ | (1,824) |  |  | $ | 1,464 |  |  | $ | 4,033 |  |  | $ | (1,923) |  |  | $ | 2,110 |
(1)During the third quarter of fiscal 2024, the Company performed a review of its intangible assets and removed from the balance sheet $1.4 billion of fully amortized gross intangible assets and the corresponding accumulated amortization associated with the assets that no longer provide an economic benefit, are no longer in use, or for which the related contract has expired. All intangible assets were subject to amortization as of March 31, 2025 and 2024. Amortization of intangible assets of the Canadian retail disposal group previously classified as held for sale and disposed in December 2024 ceased in the second quarter of fiscal 2025. Amortization expense of intangible assets was $226 million, $249 million, and $236 million for fiscal 2025, fiscal 2024, and fiscal 2023, respectively. Estimated amortization expense of the assets listed in the table above is as follows:
(In millions) |  | Estimated Amortization Expense
Fiscal 2026 |  | $ | 173 |
Fiscal 2027 |  | 168 |
Fiscal 2028 |  | 164 |
Fiscal 2029 |  | 162 |
Fiscal 2030 |  | 157 |
Thereafter |  | 640 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration